Stage IV Adult Diffuse Large Cell Lymphoma Terminated Phase 2 Trials for Cyclophosphamide (DB00531)

IndicationStatusPhase
DBCOND0028711 (Stage IV Adult Diffuse Large Cell Lymphoma)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00080847S0349 Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone With or Without Oblimersen in Treating Patients With Advanced Diffuse Large B-Cell Non-Hodgkin's LymphomaTreatment
NCT01044745Rituximab in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant for Hematologic CancerTreatment